Published in
BioMed Central, Breast Cancer Research, 1(19), 2017
DOI: 10.1186/s13058-017-0861-2
Links
- ORCID
- ORCID
- BioMed Central | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [dspace.library.uu.nl] | PDF
- [repository.tudelft.nl] | PDF
- [europepmc.org] | PDF
Tools
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting
Journal article published in 2017 by
Tesa M. Severson,
Denise M. Wolf,
Christina Yau,
Justine Peeters,
Diederik Wehkam,
Philip C. Schouten,
Suet-Feung Chin,
Ian J. Majewski 
,
Magali Michaut,
Astrid Bosma,
Bernard Pereira,
Tycho Bismeijer,
Lodewyk Wessels,
Carlos Caldas,
René Bernards
and other authors.
,
Magali Michaut,
Astrid Bosma,
Bernard Pereira,
Tycho Bismeijer,
Lodewyk Wessels,
Carlos Caldas,
René Bernards
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 